Turnaround

Pharmaceutical giant Bristol-Myers Squibb is undergoing a significant strategic transformation, marked by two major developments in key international markets this...

Moderna investors have experienced significant volatility recently as the biotech company navigated both concerning safety reports and encouraging clinical developments....

Intel has executed a significant transaction within its broader turnaround strategy, a move welcomed by investors. The semiconductor giant, which...

After months of persistent headwinds, the Ludwigshafen-based chemical giant is showing tentative signs of a potential turnaround. Technical indicators suggest...

In a landmark decision that signals a dramatic transformation for one of Germany's industrial giants, Thyssenkrupp steelworkers have overwhelmingly endorsed...

C3.ai finds itself navigating one of its most challenging periods since becoming a public company. The artificial intelligence specialist is...

SolarEdge Technologies appears to be approaching a potential inflection point following a period of mixed performance. A rare confluence of...

Energy titan Chevron is undergoing a profound corporate transformation marked by significant workforce reductions and strategic realignments. Despite this period...

The American semiconductor titan Intel is navigating the most severe crisis in its corporate history. In a dramatic dual announcement,...

After a challenging period that saw its valuation cut in half, gene-editing specialist Intellia Therapeutics appears to be building a...